Answers are grounded in this paper and cite their sources.
Isavuconazole is an extended-spectrum triazole with in vitro activity against a wide variety of fungal pathogens. Clinical isolates of molds Aspergillus lentulus and Neosartorya udagawae and yeast Cryptococcus gattii VGII (implicated in the outbreak in the Pacific Northwest, North America) exhibit reduced susceptibilities to several azoles but higher susceptibilities to isavuconazole.
No takes yet. Share an insight, caveat, or question.
Datta et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: